SANUWAVE Health, Inc. Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount
SANUWAVE Health, Inc. (SNWV) had Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount of $0 as of 2022-03-31, per its 10-Q filed 2022-05-26.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueLiabilitiesLevel2ToLevel1TransfersAmount · last filed 2022-05-26
- 2022-03-31: Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount $0.00.
- 2021-12-31: Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount $0.00.
- 2021-03-31: Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount $0.00.
- 2020-12-31: Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount $0.00.
| Period end | Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount |
|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-26 |
| 2021-12-31 | $0.00 10-K · filed 2022-05-13 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-26 |
| 2020-12-31 | $0.00 10-K · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |